Inhibrx Biosciences, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | — | -12,178.9% | -13,408.9% |
| FY2024 | — | -165,724.0% | 843,786.0% |
| FY2025 | — | -10,386.5% | -10,773.5% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | — | -12,178.9% | -13,408.9% |
| FY2024 | — | -165,724.0% | 843,786.0% |
| FY2025 | — | -10,386.5% | -10,773.5% |